Management and outcome of COVID-19 in CTLA-4 insufficiency
Description
Despite the high incidence of COVID-19 worldwide, clinical experience with SARS-COV2 in inborn errors of immunity (IEI) remains limited. Recent studies showed patients with defects in type 1 interferon (IFN)-related pathways or those with
